脳脊髄腔投与可能なDDSの開発とその脳保護効果の検討

DOI DOI Web Site Web Site PubMed 被引用文献1件 参考文献51件 オープンアクセス

書誌事項

タイトル別名
  • Development of Drug Delivery System for Intrathecal Administration and Its Therapeutic Effect on Cerebral Vasospasm and Ischemia
  • ノウ セキズイ クウ トウヨ カノウ ナ DDS ノ カイハツ ト ソノ ノウ ホゴ コウカ ノ ケントウ

この論文をさがす

説明

  To date, the pharmacologic approach to cerebral vasospasm and ischemia has been hampered in part by an inability to attain sufficiently high concentrations of drugs in the cerebrospinal fluid (CSF). To overcome this limitation of current drug therapy, we have developed a sustained-release preparation of the protein kinase inhibitor fasudil. Experimental cerebral vasospasm in rats and dogs was induced by double injection of autologous arterial blood into the cisterna magna. Focal cerebral ischemia in rats was induced by middle cerebral artery occlusion using an intraluminal suture technique. A single intrathecal injection of liposomal fasudil can maintain a therapeutic the drug concentration in the CSF due to the sustained-release property of liposomes, significantly decreasing intarct size of acute ischemia and decreasing vasoconstriction of the basilar artery in cerebral vasospasm. This novel approach for the treatment of cerebral vasospasm and ischemia may have significant potential for use in the clinical setting.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 124 (8), 541-547, 2004-08-01

    公益社団法人 日本薬学会

被引用文献 (1)*注記

もっと見る

参考文献 (51)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ